BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bio-Rad Laboratories, Inc. (BIO)'s Tour de Cure National Team Raises Over $125,000


8/28/2013 8:45:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HERCULES, CA--(Marketwired - August 27, 2013) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, once again participated as a National Team for Tour de Cure and raised over $125,000 in the organization's cycling events that took place nationwide this year to benefit the American Diabetes Association.

Bio-Rad's National Team took part in several Tour de Cure events this year with its largest presence of over 200 riders at the Napa Valley Tour de Cure, which occurred in May. As a National Team, all donations raised by Team Bio-Rad at different Tour de Cure events throughout the year are counted together to obtain one grand total.

"We are pleased to participate as a National Team in Tour de Cure," said Bio-Rad President and CEO Norman Schwartz. "It is great to see the continued interest and support of all of the participants to make Tour de Cure such a success each year. Events such as these give us all the opportunity to help improve the lives of those inflicted with this disease."

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs over 7,600 people globally and had revenues exceeding $2 billion in 2012. For more information, visit www.bio-rad.com.


Press Contact:
Bio-Rad Laboratories, Inc.
Tina Cuccia
Corporate Communications
+1 510-724-7000
Email Contact



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES